latest news in Shareholder Litigation
Kalaris Therapeutics Under Investigation Over Board Conduct Before Restructuring
New York, Tuesday, 4 August 2026.
Abbott Cooper PLLC has launched an investigation into Kalaris Therapeutics board members regarding potential breaches of fiduciary duty toward long-term shareholders prior to major corporate restructuring.
Major U.S. Corporations Face Investor Class Actions After Multi-Billion Dollar Stock Drops
Seattle, Tuesday, 4 August 2026.
Litigation firm Hagens Berman has filed securities class action lawsuits against several major U.S. companies following misleading financial reports, failed clinical trials, and sudden operational disruptions that wiped out billions in shareholder value.